Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Politics, Policy & Law

Incoming BIO CEO Crowley says priority is protecting innovation

Founder and executive chairman of Amicus to start in March, has earned trust of industry, lawmakers, patient groups

December 5, 2023 12:02 PM UTC

BIO has selected John Crowley, founder and executive chairman of Amicus, as its next CEO. He will bring hands-on experience with the challenges of leading a biotech company to the job, as well as service as a naval intelligence officer and the perspective of a father who has cared and advocated for two children with a rare disease.

Crowley will step down from his role at Amicus Therapeutics Inc. (NASDAQ:FOLD) and start his position as BIO’s CEO on March 4, 2024. Rachel King will continue to serve as BIO’s CEO until Crowley joins. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article